实体瘤-话题@MedSci

#实体瘤#

26篇内容 | 5456人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1222019, encodeId=17d71222019e3, content=<a href='/topic/show?id=aa15e612333' target=_blank style='color:#2F92EE;'>#类器官#</a><a href='/topic/show?id=13db460162d' target=_blank style='color:#2F92EE;'>#实体瘤#</a>作为模型用吧, objectTitle=Nature子刊：通过实体瘤癌症患者来源的类器官，筛选到临床候选药物, objectType=article, longId=727560, objectId=d6e0e275605c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220522/1653187599304_5635644.png, objectUrl=/article/show_article.do?id=d6e0e275605c, replyNumber=0, likeNumber=143, createdTime=2022-05-24, rootId=0, userName=清风徐来2022, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d6e0e275605c, moduleTitle=Nature子刊：通过实体瘤癌症患者来源的类器官，筛选到临床候选药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d6e0e275605c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1220478, encodeId=f18c12204e899, content=<a href='/topic/show?id=13db460162d' target=_blank style='color:#2F92EE;'>#实体瘤#</a>, objectTitle=Clin Cancer Res：TIGIT抗体Etigilimab±纳武单抗治疗晚期实体瘤, objectType=article, longId=221608, objectId=a1282216089b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2021126/1638720010525_2110107.JPG, objectUrl=/article/show_article.do?id=a1282216089b, replyNumber=0, likeNumber=140, createdTime=2022-05-17, rootId=0, userName=赛华佗, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a1282216089b, moduleTitle=Clin Cancer Res：TIGIT抗体Etigilimab±纳武单抗治疗晚期实体瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a1282216089b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1220477, encodeId=acff12204e7c1, content=<a href='/topic/show?id=13db460162d' target=_blank style='color:#2F92EE;'>#实体瘤#</a>, objectTitle=各实体瘤已上市的靶向及免疫治疗方案大盘点！, objectType=article, longId=723854, objectId=a691e2385469, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220408/1649415043188_5486984.png, objectUrl=/article/show_article.do?id=a691e2385469, replyNumber=0, likeNumber=118, createdTime=2022-05-17, rootId=0, userName=赛华佗, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a691e2385469, moduleTitle=各实体瘤已上市的靶向及免疫治疗方案大盘点！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a691e2385469)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1054553, encodeId=e9a31054553d9, content=这是<a href='/topic/show?id=13db460162d' target=_blank style='color:#2F92EE;'>#实体瘤#</a>上的创新！算是<a href='/topic/show?id=67cd829955f' target=_blank style='color:#2F92EE;'>#肿瘤浸润淋巴细胞#</a>在实体瘤上的进展了，效果应该还算不错, objectTitle=Lancet Oncology：细胞疗法用于治疗转移性葡萄膜黑色素瘤, objectType=article, longId=95291, objectId=8b9295291cd, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/webeditor/uploadfile/201704/20170410092244506.jpg, objectUrl=/article/show_article.do?id=8b9295291cd, replyNumber=0, likeNumber=187, createdTime=2021-09-24, rootId=0, userName=病毒猎手, userId=a33789389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8b9295291cd, moduleTitle=Lancet Oncology：细胞疗法用于治疗转移性葡萄膜黑色素瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8b9295291cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=951903, encodeId=074995190312, content=多任务<a href='/topic/show?id=e4cb6612395' target=_blank style='color:#2F92EE;'>#深度学习#</a>方法预测<a href='/topic/show?id=13db460162d' target=_blank style='color:#2F92EE;'>#实体瘤#</a>的治疗反应，这是一个大方向！, objectTitle=Nat Commun：多任务深度学习方法预测实体瘤患者的治疗反应, objectType=article, longId=209135, objectId=df62209135b7, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2021328/1616922832534_2467676.PNG, objectUrl=/article/show_article.do?id=df62209135b7, replyNumber=0, likeNumber=0, createdTime=2021-03-28, rootId=0, userName=病毒猎手, userId=a33789389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df62209135b7, moduleTitle=Nat Commun：多任务深度学习方法预测实体瘤患者的治疗反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df62209135b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=950517, encodeId=6aeb95051eac, content=<a href='/topic/show?id=d8104361d5' target=_blank style='color:#2F92EE;'>#CD73#</a>是<a href='/topic/show?id=13db460162d' target=_blank style='color:#2F92EE;'>#实体瘤#</a>新靶点, objectTitle=实体瘤的潜力靶点：CD73势头正猛, objectType=article, longId=185510, objectId=3d081855102a, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/webeditor/uploadfile/201912/20191231131102292.jpg, objectUrl=/article/show_article.do?id=3d081855102a, replyNumber=0, likeNumber=195, createdTime=2021-03-23, rootId=0, userName=病毒猎手, userId=a33789389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d081855102a, moduleTitle=实体瘤的潜力靶点：CD73势头正猛, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d081855102a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=908300, encodeId=c03790830060, content=<a href='/topic/show?id=51639e734cb' target=_blank style='color:#2F92EE;'>#阿司匹林#</a>治疗与降低HCV相关<a href='/topic/show?id=735a81364b7' target=_blank style='color:#2F92EE;'>#肝细胞癌#</a>HCC的风险显着相关。阿司匹林降低<a href='/topic/show?id=13db460162d' target=_blank style='color:#2F92EE;'>#实体瘤#</a>的发生是正常的，不过可能需要连续治疗很多年, objectTitle=Clin Gastroenterology H: 慢性丙型肝炎病毒感染患者每日接受阿司匹林治疗与肝细胞癌发生风险的关系, objectType=article, longId=203043, objectId=935220304387, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020117/1604718010381_2071404.jpeg, objectUrl=/article/show_article.do?id=935220304387, replyNumber=0, likeNumber=374, createdTime=2020-12-15, rootId=0, userName=lifefamily, userId=a33789389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=935220304387, moduleTitle=Clin Gastroenterology H: 慢性丙型肝炎病毒感染患者每日接受阿司匹林治疗与肝细胞癌发生风险的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=935220304387)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=901288, encodeId=a07a90128848, content=<a href='/topic/show?id=b03710396312' target=_blank style='color:#2F92EE;'>#贝洛替康#</a>有望代替<a href='/topic/show?id=1c855620260' target=_blank style='color:#2F92EE;'>#拓扑替康#</a>用于多种<a href='/topic/show?id=13db460162d' target=_blank style='color:#2F92EE;'>#实体瘤#</a>的化疗, objectTitle=Br J Cancer：拓扑替康和贝洛替康在复发性小细胞肺癌单一疗法中的疗效和安全性比较, objectType=article, longId=203653, objectId=a1a820365319, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20201122/1606038741109_2467676.PNG, objectUrl=/article/show_article.do?id=a1a820365319, replyNumber=0, likeNumber=286, createdTime=2020-11-22, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a1a820365319, moduleTitle=Br J Cancer：拓扑替康和贝洛替康在复发性小细胞肺癌单一疗法中的疗效和安全性比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a1a820365319)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=807348, encodeId=206780e348d8, content=<a href='/topic/show?id=13db460162d' target=_blank style='color:#2F92EE;'>#实体瘤#</a>, objectTitle=Clin Cancer Res：ROCK-AKT双重抑制剂AT13148治疗实体瘤的疗效和安全性, objectType=article, longId=199169, objectId=79d81991691e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/image044.jpg, objectUrl=/article/show_article.do?id=79d81991691e, replyNumber=0, likeNumber=241, createdTime=2020-08-10, rootId=0, userName=qinqiyun, userId=74c72110107, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=79d81991691e, moduleTitle=Clin Cancer Res：ROCK-AKT双重抑制剂AT13148治疗实体瘤的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=79d81991691e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

实体瘤

2020-05-29

清风徐来2022 (审核中...)

前往app查看评论内容

#类器官##实体瘤#作为模型用吧

Nature子刊：通过实体瘤癌症患者来源的类器官，筛选到临床候选药物

2022-05-24

赛华佗 (审核中...)

前往app查看评论内容

#实体瘤#

Clin Cancer Res：TIGIT抗体Etigilimab±纳武单抗治疗晚期实体瘤

2022-05-17

赛华佗 (审核中...)

前往app查看评论内容

#实体瘤#

各实体瘤已上市的靶向及免疫治疗方案大盘点！

2022-05-17

病毒猎手 (审核中...)

前往app查看评论内容

这是#实体瘤#上的创新！算是#肿瘤浸润淋巴细胞#在实体瘤上的进展了，效果应该还算不错

Lancet Oncology：细胞疗法用于治疗转移性葡萄膜黑色素瘤

2021-09-24

病毒猎手 (审核中...)

前往app查看评论内容

多任务#深度学习#方法预测#实体瘤#的治疗反应，这是一个大方向！

Nat Commun：多任务深度学习方法预测实体瘤患者的治疗反应

2021-03-28

病毒猎手 (审核中...)

前往app查看评论内容

#CD73#是#实体瘤#新靶点

实体瘤的潜力靶点：CD73势头正猛

2021-03-23

lifefamily (审核中...)

前往app查看评论内容

#阿司匹林#治疗与降低HCV相关#肝细胞癌#HCC的风险显着相关。阿司匹林降低#实体瘤#的发生是正常的，不过可能需要连续治疗很多年

Clin Gastroenterology H: 慢性丙型肝炎病毒感染患者每日接受阿司匹林治疗与肝细胞癌发生风险的关系

2020-12-15

lovetcm (审核中...)

前往app查看评论内容

#贝洛替康#有望代替#拓扑替康#用于多种#实体瘤#的化疗

Br J Cancer：拓扑替康和贝洛替康在复发性小细胞肺癌单一疗法中的疗效和安全性比较

2020-11-22

qinqiyun (审核中...)

前往app查看评论内容

#实体瘤#

Clin Cancer Res：ROCK-AKT双重抑制剂AT13148治疗实体瘤的疗效和安全性

2020-08-10

科室
- - 订阅+
  - 更多科室
工具
服务